Search
for
Sort by
Research 241–270 of 817
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The therapeutic use of androgens in women
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Nonclassic Congenital Adrenal Hyperplasia
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Idiopathic Hirsutism*
- Regulation of masculinization: androgen signalling for external genitalia development
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hirsutism: Diagnosis and management
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Redefining hormone resistance in prostate cancer
- Current evaluation of amenorrhea
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Pharmacotherapy of polycystic ovary syndrome - an update
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*